Spots Global Cancer Trial Database for hyperglycemia
Every month we try and update this database with for hyperglycemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients | NCT04300790 | Breast Cancer | Alpelisib Metformin Fulvestrant Letrozole Exemestane Vildagliptin Tamoxifen | 18 Years - | MedSIR | |
| Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN) | NCT02216799 | Diabetic Patien... | Glargine Insuli... Regular insulin | 18 Years - | King Faisal Specialist Hospital & Research Center | |
| Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) | NCT00500240 | Leukemia Lymphoma | Insulin Glargin... Insulin Aspart | 15 Years - | M.D. Anderson Cancer Center | |
| Glucose Variability in Cancer Patients Receiving Dexamethasone | NCT02372539 | Hyperglycemia Cancer | Diabetes Control Group | 18 Years - 75 Years | University of Colorado, Denver | |
| Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly | NCT02060383 | Cushing's Disea... Acromegaly | Pasireotide s.c... Sitagliptin Liraglutide Insulin Pasireotide LAR Metformin | 18 Years - | Novartis | |
| Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes | NCT02248272 | Impaired Glucos... Hyperinsulinism Poor Glycemic C... Hyperglycemia Insulin Sensiti... | Isocaloric diet... Isocaloric diet... | - | Harokopio University | |
| Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes | NCT02248272 | Impaired Glucos... Hyperinsulinism Poor Glycemic C... Hyperglycemia Insulin Sensiti... | Isocaloric diet... Isocaloric diet... | - | Harokopio University | |
| Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477) | NCT04330625 | Hyperglycemia D... | REMD-477 | 18 Years - | Duke University | |
| Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes | NCT02248272 | Impaired Glucos... Hyperinsulinism Poor Glycemic C... Hyperglycemia Insulin Sensiti... | Isocaloric diet... Isocaloric diet... | - | Harokopio University | |
| Glucose Variability in Cancer Patients Receiving Dexamethasone | NCT02372539 | Hyperglycemia Cancer | Diabetes Control Group | 18 Years - 75 Years | University of Colorado, Denver | |
| Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia | NCT03904199 | Hyperglycemia | Insulin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Early Detection Initiative for Pancreatic Cancer | NCT04662879 | Hyperglycemia Diabetes Mellit... Pancreas Ductal... | Enriching New-o... Abdominal imagi... | 50 Years - 85 Years | Pancreatic Cancer Action Network | |
| Glycemic Impact on Glioblastoma Outcomes | NCT03235934 | Glioblastoma Mu... Hyperglycemia | 18 Years - | University Health Network, Toronto | ||
| Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients | NCT02012465 | Lymphoma Diabetes Mellit... Hyperglycemia | Insulin protoco... | 18 Years - | Washington University School of Medicine | |
| Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly | NCT02060383 | Cushing's Disea... Acromegaly | Pasireotide s.c... Sitagliptin Liraglutide Insulin Pasireotide LAR Metformin | 18 Years - | Novartis | |
| Glucose Monitoring During Chemotherapy | NCT04473378 | Breast Cancer Hyperglycemia | FreeStyle Libre... | 18 Years - | Columbia University | |
| Glucose Variability in Cancer Patients Receiving Dexamethasone | NCT02372539 | Hyperglycemia Cancer | Diabetes Control Group | 18 Years - 75 Years | University of Colorado, Denver | |
| Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant | NCT01236885 | Hyperglycemia Malignant Neopl... | computer-assist... | 18 Years - | Fred Hutchinson Cancer Center | |
| Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib | NCT06083038 | Metastatic Brea... | Alpelisib FreeStyle Libre... | 18 Years - | HealthPartners Institute | |
| Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes | NCT02248272 | Impaired Glucos... Hyperinsulinism Poor Glycemic C... Hyperglycemia Insulin Sensiti... | Isocaloric diet... Isocaloric diet... | - | Harokopio University | |
| Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN) | NCT02216799 | Diabetic Patien... | Glargine Insuli... Regular insulin | 18 Years - | King Faisal Specialist Hospital & Research Center | |
| Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant | NCT04899349 | Breast Cancer | Alpelisib Fulvestrant Metformin XR Dapagliflozin +... Dapagliflozin | 18 Years - | Novartis | |
| Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) | NCT04373265 | Adrenocortical ... | Relacorilant Pembrolizumab | 18 Years - | Corcept Therapeutics | |
| Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib | NCT06083038 | Metastatic Brea... | Alpelisib FreeStyle Libre... | 18 Years - | HealthPartners Institute | |
| Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients | NCT04300790 | Breast Cancer | Alpelisib Metformin Fulvestrant Letrozole Exemestane Vildagliptin Tamoxifen | 18 Years - | MedSIR | |
| Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib | NCT06083038 | Metastatic Brea... | Alpelisib FreeStyle Libre... | 18 Years - | HealthPartners Institute | |
| Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) | NCT00500240 | Leukemia Lymphoma | Insulin Glargin... Insulin Aspart | 15 Years - | M.D. Anderson Cancer Center | |
| Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant | NCT04899349 | Breast Cancer | Alpelisib Fulvestrant Metformin XR Dapagliflozin +... Dapagliflozin | 18 Years - | Novartis | |
| Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia | NCT00943709 | Hyperglycemia Leukemia | insulin glargin... therapeutic ins... | 18 Years - | Rutgers, The State University of New Jersey | |
| The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib | NCT05081765 | Ovary Cancer | Lynparza® (Astr... Lynparza | 18 Years - | Poznan University of Medical Sciences | |
| Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) | NCT00500240 | Leukemia Lymphoma | Insulin Glargin... Insulin Aspart | 15 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
